How our MD Oncologist was able to convert a No-merit case to a winning one!!!

Our client asked us to review whether the Dermatologist committed malpractice by not informing of Squamous Cell Carcinoma almost 10 months after the diagnosis. Our doctors opined that the negligence did not cause actual damages such as pain, emotional distress, additional medical expenses, or loss of ability to work or earn money. Hence, there was no merit in this case.

However, our MD Oncologist identified a new deviation in the standard of treatment of haematuria, which led to the delayed diagnosis of bladder cancer. The prognosis of that patient would have been better (up to 95% survival rate) with an early diagnosis

Focus points given by client: A mole biopsy was done for the plaintiff. Even after 10 months, he was not informed that he had Squamous Cell Carcinoma. Our MDs had to determine whether Dr. X(Dermatologist) committed malpractice by missing the cancer diagnosis.

Our MD Oncologist’s Review:

Our MD has opined that Dr. X(Dermatologist) had deviated from the standard of care by failing to properly review the histopathology report of the biopsy of the papule on the left upper back. There was no impact on the prognosis of the plaintiff due to the delay in the excision of the left shoulder squamous cell carcinoma.

Dr. Y (Family Medicine) had deviated from the standard of care. He had failed to investigate the cause of the haematuria. Based on the expert opinion, the most appropriate step would have been an ultrasound of the abdomen and pelvis or a CT scan of the abdomen and pelvis to evaluate the cause of the haematuria.

Dr. Y failed to order an ultrasound of the abdomen and pelvis or a CT of the abdomen and pelvis. It is more likely than not that the microscopic hematuria could have been due to the early stage of carcinoma of the bladder.

The patient was diagnosed with a localized urothelial carcinoma. Both stage I and stage II bladder cancers are localized 

As a result of this delay in diagnosis, the patient’s 5-year survival rate was significantly impacted. Stage II bladder cancer has a 5-year survival rate of 69%, whereas stage 0 in situ bladder cancer has a 5-year survival rate of 95%.

Our expert review helped our client make a confident decision about whether to move forward with their case. Let us help you too!

If you want to see a full sample of our medical opinion, just email us at [email protected]!

With over 5000 medical opinions under our belt, we have the expertise you need. Our areas of expertise include:

  • Anesthesia errors
  • Childbirth injuries
  • Delayed diagnosis
  • Medication errors
  • Misdiagnosis
  • Negligent prenatal care
  • Nursing home abuse
  • Pressure ulcers
  • Surgery errors
  • Treatment errors

    Don’t settle for less, trust the experts at Trivent MD.

All pages

© 2024 • Trivent Inc • All Rights Reserved. Trivent is not a law firm and does not give a legal opinion.